DCT

2:23-cv-03530

Boehringer Ingelheim Pharma Inc v. Anobri Pharma US LLC

General

Filed

06/29/23

Cause of ActionPatent Infringement

SectorTransport., E-Comm.

StatusOpen

Patent Owner

Operating Company

PACER2:23-cv-03530

Nature of Suit835 ANDA

CourtD. New Jersey

Judge	Period	PO Win Rate
Claire C. Cecchi	--	74%

Plaintiff

Party

Name	Ratings
Boehringer Ingelheim Pharmaceuticals Inc NPE	L4A
Boehringer Ingelheim Intl GmbH	L4A

Attorney

Name	Ratings
Covington & Burling LLP	L4B
Eric R. Sonnenschein	L5A
Christopher N. Sipes	L5C
R. Jason Fowler	L5C
Sarahi Uribe	L2C
Justin W. Burnam	---- --
Alyssa R. Greenstein	---- --
Saul Ewing LLP	L4B
William C. Baton	L5A
Charles M. Lizza	L5A
Sarah Ann Sullivan	L4A

Defendant

Party

Name	Ratings
Anobri Pharmaceuticals US LLC	---- --

Attorney

Name	Ratings
Hill Wallack LLPLocal	L3E
Eric I. Abraham	L5E
Kristine L. Butler	L1D
William Murtha	L1D
Stephanie-Rose Orlando	---- --
Procopio Cory Hargreaves Savitch LLP	L2D
Steven A. Maddox	L5E
Jeremy J. Edwards	L5E
Xiaofan Yang	---- --
Attorney at LawLocal	---- --
Cecil K. Musgrove	---- --
Elizabeth M. Crompton	---- --
Scott Cunning	---- --
Brett Garrison	---- --
C. Kyle Musgrove	---- --